Last quarter (Q4 2023), Bright Minds Biosciences's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, Bright Minds Biosciences's net income was C$―. See Bright Minds Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20
Total Revenue	-	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expense	C$ 4.92M	C$ 7.39M	C$ 14.98M	C$ 8.79M	C$ 474.81K
Operating Income	C$ -4.92M	C$ -7.39M	C$ -14.98M	C$ -8.79M	C$ -474.81K
Net Non Operating Interest Income Expense	-	-	-	C$ -18.66K	C$ -5.57K
Other Income Expense	C$ -73.78K	-	C$ 2.00K	C$ 154.10K	-
Pretax Income	C$ -4.99M	C$ -7.37M	C$ -14.96M	C$ -8.65M	C$ -480.38K
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	C$ -4.99M	C$ -7.37M	C$ -14.96M	C$ -8.65M	C$ -480.38K
Basic EPS	C$ -0.35	C$ -1.98	-	C$ -0.96	C$ -0.08
Diluted EPS	C$ -0.35	C$ -1.98	C$ -1.21	C$ -0.96	C$ -0.08
Basic Average Shares	C$ 29.80M	C$ 3.72M	C$ 12.35M	C$ 8.97M	C$ 5.79M
Diluted Average Shares	C$ 29.80M	C$ 3.72M	C$ 12.35M	C$ 8.97M	C$ 5.79M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	C$ 4.92M	C$ 7.39M	C$ 14.98M	C$ 8.79M	C$ 474.81K
Net Income From Continuing And Discontinued Operation	C$ -4.99M	C$ -7.37M	C$ -14.96M	C$ -8.65M	C$ -480.38K
Normalized Income	C$ -4.96M	-	-	C$ -8.80M	C$ -480.38K
Interest Expense	-	-	-	-	-
EBIT	C$ -4.92M	-	C$ -14.96M	C$ -8.79M	C$ -474.81K
EBITDA	C$ -4.90M	-	C$ -14.96M	C$ -8.79M	C$ -474.81K

Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing